U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older
TAKHZYRO is the First and Only Prophylaxis Treatment Approved in the U.S. for Children 2…
TAKHZYRO is the First and Only Prophylaxis Treatment Approved in the U.S. for Children 2…
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--This week, Japan saw record numbers of people dying from COVID-19, the…
SINGAPORE--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating of B++ (Good) and a Long-Term…
HONG KONG--(BUSINESS WIRE)--#insurance--AM Best has downgraded the Long-Term Issuer Credit Rating (Long-Term ICR) to “a”…
GOHEUNG, South Korea--(BUSINESS WIRE)--#PureBrightNWarmCooperative--Pure Bright and Warm Cooperative (CEO Taek Sang Kwon, ‘Cooperative’) announced its…
SÃO PAULO & NEW YORK & SHANGHAI--(BUSINESS WIRE)--Suzano, the world’s largest hardwood pulp producer, will…
SCOTTSDALE, Ariz. & SINGAPORE & CHICAGO--(BUSINESS WIRE)--STORE Capital Corporation (NYSE: STOR, “STORE”, “STORE Capital” or…
HONG KONG--(BUSINESS WIRE)--Hong Kong Tourism Board: Media can download the photos and videos footage…
NEW YORK--(BUSINESS WIRE)--Uptime Institute, the Global Digital Infrastructure Authority, a Dominus Capital, L.P. portfolio company,…
Novel compact, single-story 4 Kelvin 1.0 GHz NMR systems already accepted at RIKEN, Japan and…